Buy Crypto
Markets
Spot
FuturesBTC
Earn
Event Center
Rewards Hub
More
100%+ PoR
PFE

Pfizer Inc. (PFE)

NYSE
$28.06
-$0.44
(-1.55%)
Previous Close: ⁦$28.47⁩
Market Closed

Last updated: ⁦2026-11-19 08:15:40⁩. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.

Summary

Pfizer Inc. (PFE) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $28.06, with a market capitalization of $162.27B and a P/E ratio of 40.24. Over the past 52 weeks, its price has ranged from $23.62 to $31.44. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

$162.27B

$28.06

$28.53

$28.02

$28.47

26.93M

33.47M

40.24

$31.44

$23.62

6.03%

2026-09-27

Pfizer Inc. (PFE) Latest Closing Stock Price

Pfizer Inc. (PFE) last closed at $28.06 as of 2026-11-19 00:59:28, down 1.55% ($0.44) from the previous close of $28.47.

During the latest regular trading session, PFE traded between $28.02 and $28.53, with a volume of 26.93M shares. The closing price was near the lower end and near the middle of its 52-week range.

Pfizer Inc. (PFE) 7-Day Stock Price Change

Over the past seven days, Pfizer Inc. (PFE) moved from $29.36 to $28.06, representing a decline of 4.41% ($1.30).

The stock traded between $28.00 and $29.77 during the period. The latest price is near the lower end of the 7-day range, indicating moderate downward.

The average daily volume was 31.81 million shares, down versus the previous seven-day period, indicating lower trading activity.

PFE 52-Week Price Position

Position in Range: 56.8%

52W Low$23.62
52W High$31.44

PFE is currently trading at $28.06, placing it 56.8% of the way from its 52-week low of $23.62 to its 52-week high of $31.44. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Pfizer Inc. (PFE)?

Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndamax and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.

Pfizer Inc. Information

Industry
PHARMACEUTICAL PREPARATIONS
Employees
75,000
CEO
Albert Bourla
Founded
1849
Exchange
NYSE
Company Website

PFE Stock Events

View the latest dividend and stock split events for Pfizer Inc.

Dividend
Ex-Dividend DateNov 6, 2026
Payment DateDec 7, 2026
Dividend Per Share$0.43

PFE News

Latest news related to Pfizer Inc. and PFE stock.

  • Massive

    NSCLC Treatment Landscape Shifts as ESMO 2026 Spotlights MET, KRAS, and TROP2 Advances, Says DelveInsight

    The non-small cell lung cancer market is shifting toward precision, biomarker-guided treatment sequencing. ESMO 2026 presented Phase III data showing savolitinib plus osimertinib improved survival in MET-altered EGFR-mutated NSCLC, divarasib outperformed approved KRAS G12C inhibitors, and TROP2-directed ADCs demonstrated durable gains. The 7MM NSCLC market is projected to double from USD 33 billion in 2025 to USD 67 billion by 2036, driven by expanded screening, biomarker-driven therapies, and label expansions into earlier-stage disease.

    Read Full Article
  • Massive

    Pharmaceutical Market to Reach USD 3.20 Trillion by 2035 as Obesity and Oncology Drugs Lead Growth and U.S. Pricing Deals and Tariffs Reshape Manufacturing

    The global pharmaceutical market is valued at USD 1.88 trillion in 2026 and is projected to reach USD 3.20 trillion by 2035 at a CAGR of 6.10%. Growth is concentrated in obesity and oncology therapies, with U.S. pricing deals and Section 232 tariffs reshaping manufacturing. North America holds 42% of the market, while companies with strong positions in GLP-1 medicines and cancer therapies are growing significantly faster than the market.

    Read Full Article
  • Benzinga

    Pfizer Strikes Multibillion-Dollar Deal to Take on Autoimmune Diseases

    Pfizer signs up to $2.63B licensing deal with Starna Therapeutics for in vivo CAR-T autoimmune therapies, paying $330M upfront.

    Read Full Article
  • Benzinga

    Pfizer Signs Exclusive Licensing Agreement With Starna Therapeutics To Commercialize Three Pre-IND In Vivo Chimeric Antigen Receptor T-Cell Programs Outside Of China For $330M Up Front And Up To $2.3B In Milestones

    Deal Terms and Financial DetailsStarna will receive an upfront payment of $330 million.Starna is eligible to receive up to $2.3 billion in milestone payments associated with certain development and commercial

    Read Full Article
  • Massive

    Biotechnology Market Companies 2027 Analysis: Amgen, Gilead, Regeneron, Vertex and Moderna Post Strong 2026 Results as Billion-Dollar Deals Reshape a Market Headed for USD 6.34 Trillion by 2035

    The global biotechnology market, valued at USD 2.02 trillion in 2026, is projected to reach USD 6.34 trillion by 2035 at a 13.61% CAGR. Leading biotech companies including Amgen, Gilead, Regeneron, Vertex, and Moderna reported strong Q3 2026 results with revenue growth ranging from 8% to 36%. The sector experienced record dealmaking activity with major acquisitions totaling tens of billions of dollars, driven by patent expiries, strong cash flows, and strategic pipeline expansion in oncology, immunology, and advanced therapies.

    Read Full Article

Ways to Trade PFE at MEXC

PFE MEXC RealStocks

Own real PFE shares through MEXC's regulated brokerage partner.


Suitable for long-term holding.

  • Own the actual shares
  • Receive dividends and voting rights
  • Buy fractional shares starting at $1

PFE Tokenized Stocks

Get PFE price exposure through a blockchain-based token.


Suitable for trading outside U.S. market hours.

  • Token tracks the PFE price
  • Trade 24/7
  • Trade on weekends and holidays

PFE Stock Futures

Trade PFE price movements with futures contracts.


Suitable for short-term positions.

  • Go long or short
  • Trade 24/7
  • Up to 20x leverage

How to Buy Pfizer Inc. (PFE) Stock on MEXC

Eligible investors can buy real shares of Pfizer Inc. (PFE) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account
Step 1: Open and Verify Your RealStocks Account
Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.
Step 2: Transfer USDT to Your RealStocks Account
Step 2: Transfer USDT to Your RealStocks Account
Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.
Step 3: Search for PFE and Place Your Order
Step 3: Search for PFE and Place Your Order
Open the RealStocks trading page and search for PFE. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Pfizer Inc. (PFE) stock price today?
Pfizer Inc. (PFE) is currently trading at $28.06, down 1.55% ($0.44) from the previous close of $28.47. Intraday prices update in real time during regular trading hours.
2.Is PFE stock going up or down today?
As of 2026-11-19 00:59:28, PFE is trading at $28.06, down 1.55% ($0.44) from its previous close of $28.47. The stock has traded between $28.02 and $28.53 during today’s regular session. Past price movements do not guarantee future results.
3.What is PFE pre-market price?
As of 2026-11-19 00:59:28, PFE is trading at $28.21 in pre-market trading, down 0.91% ($0.26) from the previous close of $28.47. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.
4.What is PFE after-hours price?
As of 2026-11-19 00:59:28, PFE is trading at $28.04 in after-hours trading, down 0.10% ($0.03) from the regular-session close of $28.06. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.
5.Is PFE stock trading now?
PFE trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.
6.Where does PFE sit relative to its 52-week high and low?
Over the past 52 weeks, PFE has traded between a low of $23.62 and a high of $31.44. At $28.06, the stock is positioned 56.8% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.
7.What sector is Pfizer Inc. in?
Pfizer Inc. (PFE) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.
8.What is Pfizer Inc.'s market capitalization and where is it listed?
Pfizer Inc. is listed on the NYSE exchange with a market capitalization of $162.27B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.
9.How is PFE valued in terms of P/E ratio and EPS?
PFE trades at a P/E ratio of 40.24, based on trailing-twelve-month EPS of $0.71. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.
10.Does Pfizer Inc. pay a dividend?
Pfizer Inc. pays an indicated annual cash dividend of $1.69 per share, with a current dividend yield of 6.03% based on the latest share price. Dividend policies are subject to change at the board's discretion.

Explore More US Stocks

Stocks in the Same Sector

Browse other US stocks in the same sector as Pfizer Inc.

Largest Market Cap

See US stocks with the highest market capitalization

Most Actively Traded

Discover today's most actively traded US stocks

Top 5 Cryptocurrencies

Explore the cryptocurrencies with the highest market capitalization

Compliance Disclosure and Data Source

Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to PFE, including Stocks, Tokenized Stocks, and Stock Futures.

Disclaimer

The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.

Search Stocks

PFE Stock Calculator

Estimate the value between PFE shares and USD.

PFE Shares to USD

PFE Shares
PFE
PFE
USD
USD
USD

1.00 PFE shares = 28.064 USD

Calculations are estimates based on the latest available price and are for reference only.